Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Singapore Institute of Advanced Medicine Holdings Ltd. ( (SG:9G2) ) has provided an announcement.
Singapore Institute of Advanced Medicine Holdings Ltd. has received approval from the SGX-ST for the listing and quotation of 169,474,000 new shares. This includes a debt conversion of 149,726,000 shares from Caterine Limited and a placement of 19,748,000 shares at S$0.035 each. The listing is subject to compliance with SGX-ST’s requirements, and the shares must be placed within seven market days. The SGX-ST has noted potential implications for substantial acquisitions or reverse takeovers if the company acquires assets from related parties.
More about Singapore Institute of Advanced Medicine Holdings Ltd.
Singapore Institute of Advanced Medicine Holdings Ltd. operates in the medical industry, focusing on advanced medical services and technologies. The company is based in Singapore and was incorporated in 2011.
Average Trading Volume: 458,926
Technical Sentiment Signal: Buy
Find detailed analytics on 9G2 stock on TipRanks’ Stock Analysis page.